Cargando…
How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
SIMPLE SUMMARY: Unresectable hepatocellular carcinoma (HCC) is the main type of primary liver cancer and poses a challenge to the healthcare system across the world. Immune checkpoint inhibitor (ICI)-based immunotherapy has become a recent focus of HCC treatment. However, its high risk of treatment-...
Autores principales: | Fu, Yan, Zeng, Chu Hui, An, Chao, Liu, Yue, Shin, Ji Hoon, Li, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954096/ https://www.ncbi.nlm.nih.gov/pubmed/36831664 http://dx.doi.org/10.3390/cancers15041324 |
Ejemplares similares
-
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
por: Brandi, Nicolò, et al.
Publicado: (2023) -
Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021) -
Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
por: Biondetti, Pierpaolo, et al.
Publicado: (2021) -
Image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: Current status
por: Qian, Kun, et al.
Publicado: (2020) -
Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)